155 related articles for article (PubMed ID: 12023519)
1. Evaluation of CB1 receptor knockout mice in the Morris water maze.
Varvel SA; Lichtman AH
J Pharmacol Exp Ther; 2002 Jun; 301(3):915-24. PubMed ID: 12023519
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task.
Varvel SA; Cravatt BF; Engram AE; Lichtman AH
J Pharmacol Exp Ther; 2006 Apr; 317(1):251-7. PubMed ID: 16352706
[TBL] [Abstract][Full Text] [Related]
3. Exposure to marijuana smoke impairs memory retrieval in mice.
Niyuhire F; Varvel SA; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2007 Sep; 322(3):1067-75. PubMed ID: 17586723
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
5. Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice.
Varvel SA; Anum EA; Lichtman AH
Psychopharmacology (Berl); 2005 Jun; 179(4):863-72. PubMed ID: 15619104
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
Patel S; Hillard CJ
J Pharmacol Exp Ther; 2006 Jul; 318(1):304-11. PubMed ID: 16569753
[TBL] [Abstract][Full Text] [Related]
7. Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs.
Desai RI; Thakur GA; Vemuri VK; Bajaj S; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2013 Feb; 344(2):319-28. PubMed ID: 23197773
[TBL] [Abstract][Full Text] [Related]
8. Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline.
Varvel SA; Anum E; Niyuhire F; Wise LE; Lichtman AH
Psychopharmacology (Berl); 2005 Mar; 178(2-3):317-27. PubMed ID: 15322725
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
[TBL] [Abstract][Full Text] [Related]
10. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice.
Da S; Takahashi RN
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):321-5. PubMed ID: 11817511
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models.
Smith SR; Denhardt G; Terminelli C
Eur J Pharmacol; 2001 Nov; 432(1):107-19. PubMed ID: 11734194
[TBL] [Abstract][Full Text] [Related]
12. SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats.
Lichtman AH
Eur J Pharmacol; 2000 Sep; 404(1-2):175-9. PubMed ID: 10980277
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of delta 9-THC on spatial reference and working memory in mice.
Varvel SA; Hamm RJ; Martin BR; Lichtman AH
Psychopharmacology (Berl); 2001 Sep; 157(2):142-50. PubMed ID: 11594438
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid ligands and their effects on learning and performance in rhesus monkeys.
Winsauer PJ; Lambert P; Moerschbaecher JM
Behav Pharmacol; 1999 Sep; 10(5):497-511. PubMed ID: 10780256
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-independent relaxation to cannabinoids in rat-isolated mesenteric artery and role of Ca2+ influx.
Ho WS; Hiley CR
Br J Pharmacol; 2003 Jun; 139(3):585-97. PubMed ID: 12788818
[TBL] [Abstract][Full Text] [Related]
16. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoids R(-)-7-hydroxy-delta-6-tetra-hydrocannabinol-dimethylheptyl (HU-210), 2-O-arachidonoylglycerylether (HU-310) and arachidonyl-2-chloroethylamide (ACEA) increase isoflurane provoked sleep duration by activation of cannabinoids 1 (CB1)-receptors in mice.
Schuster J; Ates M; Brune K; Gühring H
Neurosci Lett; 2002 Jul; 326(3):196-200. PubMed ID: 12095655
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological effects of cannabinoids on the reference and working memory functions in mice.
Avdesh A; Hoe Y; Martins RN; Martin-Iverson MT
Psychopharmacology (Berl); 2013 Jan; 225(2):483-94. PubMed ID: 22903389
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid pharmacological properties common to other centrally acting drugs.
Wiley JL; Martin BR
Eur J Pharmacol; 2003 Jun; 471(3):185-93. PubMed ID: 12826237
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
Järbe TU; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
